Origin of Weir’s photo, AFP
We call it a diss photo, but health workers in Goma will be vaccinated first
It’s been 2 hours
Several African contrines have begun vaccinations to curb the rapid spread of mpox, formerly known as monkeypox virus.
It is the first time that these vaccines will be used in large-scale vaccination programs across Africa to reach thousands of vulnerable people.
According to the World Health Organization (WHO), there have been 16 cases across the continent since the beginning of the year.
Ghana recorded its first MPOX incident last week.
According to the Africa Centers for Disease Control and Prevention (CDC), there are an estimated 22,000 confirmed cases and more than 700 deaths in most parts of the Democratic Republic of the Congo (DR Congo). Most of the country (Congo) is affected by Mpox.
There are concerns that the numbers are in line with the higher readings, but limited testing and insufficient contact tracing mean the record is far from fitting.
The Democratic Republic of Congo plans to roll out vaccinations in the city of Goma, one of the worst-affected areas in D’Icontri region.
Nigeria has started to see an increase in MPOX cases, with more than 70 cases confirmed so far.
The Ministry of Health plans to target high-risk groups in some states such as Ogun, Akwa Ibom, Plateau, Cross River and Abia states. However, on Wednesday, October 9, authorities announced that they would not postpone the rollout plan.
Rwanda became Africa’s first country to introduce the mpox vaccine last month, but the country is currently battling two outbreaks: mpox and the deadly Marburg virus.
Rwanda’s Ministry of Health has announced that it will begin clinical trials of an experimental Marburg vaccine and treatment in the coming weeks.
Here’s what you need to know – which vaccines are available?
Origin of Weir’s photo, AFP
Wechin’ what we call diss photos, Democrats originally used a version of Dimpox vaccine to fight smallpox
The world health organization (who) recommends three different vaccines for use against mpox.
Di MVA-BN is from Bavarian Scandinavia in Denmark and is also known as the Di Ginneos vaccine. Nagy is the first vaccine that WHO will add to its prequalification list in September.
The pre-qualification process is to ensure that health products meet global standards of quality, safety and effectiveness.
The two vaccines recommended by Health Body are LC-16, manufactured by Japan’s KM Biologics, and ACAM2000, manufactured by U.S.-based Sanofi Pasteur Biologics LLC.
After vaccination, it takes about two weeks to become fully protected.
One version of these vaccines was originally used to fight smallpox, and the WHO announced it was globally discontinued in 1980. The last case of the disease was recorded in Africa in 1977 in Somalia.
Smallpox virus and mpox virus belong to the same family and are called orthopoxviruses.
They have similar properties and cause the same symptoms such as rash and fever.
Who will go to receive these vaccines?
Origin of Wia’s photo, Getty Images
We call it a photo, but the EU medicines regulator approves the use of MVA-BN vaccine in adolescents
The WHO does not recommend vaccinating the entire population against Contris, saying it strongly recommends that the vaccine be used only in high-risk groups.
These groups include health care workers, close contacts of MPOX (including children), close contacts of multiple sexual partners, and men who are involved in sexual relationships with men and sex workers. Masu.
During the 2022 global MPX outbreak, Democrats linked most cases to sex acts between gay, bisexual, and queer men, claiming that gay men are having sex with men. The D-clade 2 strain of Divirus vindei is responsible for the outbreak.
The spread of the current outbreak varies across East and Central Africa, according to the CDC. Although the three different cases do not cause Dimpox strains, they can affect different groups and geographic regions of Pipo.
Are children vaccinated?
According to the WHO, so far, LC-16 is the only drug officially approved for use in pipo in people under 18 years of age.
In special cases, the MVA-BN vaccine should only be used for pipo under 18 years of age. This is one approach commonly known as “off-label” use.
It’s mean to say that it’s appropriate to use it in an emergency to protect a lot of pipo in an emergency.
For example, the Democratic Republic of the Congo believes that many children are not affected. Di ACAM2000 is not recommended for children.
Recently, the European Union’s medicines regulator approved the MVA-BN vaccine for adolescents.
How do I get the vaccine?
The MVA-BN vaccine is given in two doses, 28 days apart, and is injected into the upper arm in the morning.
The two vaccines are given in one dose and are administered using one special bifurcated needle.
To administer the vaccine under the skin during vaccination, a needle is used to pick the skin several times and usually a single small lesion will appear after the injection is made.
What are the side effects?
Origin of Weir’s photo, AFP
Vaccination, as we call it “photos”, first of all reduces the risk of infection and helps protect against serious illness during infection.
As with most vaccines, some Pipofit users experience no side effects at all, while Odafit users may experience mild pain or swelling, itching, fatigue, headache, muscle aches, nausea, or mild fever after the injection. I will.
Can I still get mpox even though I’ve been vaccinated?
Yes, it is possible to get infected with M.P.O.X. even if you are not vaccinated, but according to the WHO and the Africa CDC, it is less likely.
Vaccination helps reduce the risk of infection in the first place and protects you from serious illness during infection.
Pesin’s overall health or age compatibility can affect the duration of protection from vaccination. For example, if a person’s immune system is weakened due to some underlying disease, they are more vulnerable.
Will these vaccines prove effective against the new mpox clade 1b?
Dr. Samuel Boland, WHO’s regional Mpox incident manager for Africa, said researchers are looking ahead to 2022, when the global pandemic begins, to determine how effective these vaccines will be. It has not been possible to collect data about.
Available data shows that the vaccine is effective once all doses have been administered.
They said that while studying vaccines specific to the newly identified clade 1b, the vaccines “offer cross-protection,” and they are not sure how effective the mpox vaccine is in different locations. He said he is conducting further research to find out.
Dr Borland told BBC News that the WHO will be monitoring the virus for mutations that could change the way it spreads and the effectiveness of treatments. The organization says it is prepared to adjust its public health strategy as necessary.
Africa CDC Director Gene Kaseya said the approved MVA-BN vaccine is effective and should be used against clade 1b MPOX variants.
What does Wetin think he would do if he developed symptoms?
If you develop symptoms such as fever, headache, muscle aches, back pain, fatigue, swollen glands (lymph nodes), or rash, or if you have any questions or concerns about the virus, contact your local health care provider. Please seek assistance.
